FDA — authorised 3 December 2014
- Application: BLA125557
- Marketing authorisation holder: AMGEN
- Local brand name: BLINCYTO
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Blincyto in United States
FDA authorised Blincyto on 3 December 2014
Marketing authorisation
Blincyto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Blincyto approved in United States?
Yes. FDA authorised it on 3 December 2014.
Who is the marketing authorisation holder for Blincyto in United States?
AMGEN holds the US marketing authorisation.